SBI Contra Fund Direct Growth NAV Advances to ₹409.70 on 21 September; TREPS Forms Largest Disclosed Allocation

Key Takeaways

• SBI Contra Fund Direct Growth NAV increased by 0.33% to ₹409.70 on 21 September 2026.
• Its latest one-year return was -3.48%; the three-year and five-year CAGRs stood at 10.46% and 14.84%, respectively.
• TREPS was the largest disclosed allocation at 7.11%, whereas Reliance Industries was the largest listed equity position at 4.75%.

SBI Contra Fund Direct Growth NAV moved to ₹409.70 on 21 September 2026, gaining 0.33% over the previous valuation. The scheme managed approximately ₹47,589 crore and carried a Direct Growth expense ratio of 0.86%. Its minimum SIP was ₹500, with the minimum lump-sum investment at ₹5,000.

The latest one-year return was -3.48%. Extending the period changes the historical picture: the three-year CAGR was 10.46%, and the five-year annualised return reached 14.84%. The five-year figure exceeded the three-year CAGR by 4.38 percentage points, and the gap versus the latest one-year return was substantially wider.

TREPS represented 7.11% of the disclosed portfolio and was the largest overall allocation among the entries shown. It should be distinguished from an equity holding. Reliance Industries was the largest listed stock at 4.75%, followed by ICICI Bank at 4.55%, HDFC Bank at 4.54% and Biocon at 3.47%. Including TREPS, those five entries totalled 24.42%, leaving 75.58% elsewhere in the portfolio.

Historical risk statistics showed an alpha of 6.34, standard deviation of 4.06, beta of 0.98 and Sharpe ratio of 0.55. A beta close to one describes historical sensitivity relative to the benchmark used for the calculation; it does not establish how the next day's NAV will behave.

The scheme follows a contra-oriented equity strategy. Its exit-load schedule was tiered by holding period: 0.25% for applicable exits within 30 days and 0.10% from more than 30 days through 90 days, with no exit load after 90 days under the disclosed terms